Plain-English translation of NCT06635525 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether advanced kidney disease affects how well your body's immune system responds to the influenza vaccine. This observational study will track people on dialysis and compare their vaccine response to people without kidney problems. By measuring protective antibodies in your blood over 4 months, the team hopes to learn whether dialysis patients need different vaccination strategies.
People with advanced kidney disease on dialysis often have weaker immune systems, but it's unclear exactly how kidney failure affects vaccine protection. This study aims to fill that gap so doctors can better protect dialysis patients from the flu.
You likely qualify if…
You likely don't qualify if…
You will receive a flu vaccine at your enrollment visit, then return to the clinic for blood draws at days 7, 14, 30, 60, and 120 after vaccination. At each visit, you'll provide a small blood sample and answer questions about your health history. The entire study lasts 4 months, and researchers will measure whether your body develops protective antibodies against the flu.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Italy